Immune checkpoint inhibitor-related myositis and myocarditis in patients with cancer

Abstract

irMyositis presents with remarkably homogeneous and unique clinicopathologic features, expanding the nosologic spectrum of inflammatory myopathies in patients with cancer. ICI withdrawal and treatment with corticosteroids improve outcome.